---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-081531"
form_type: "8-K"
ticker: "TERN"
cik: "0001831363"
company_name: "Terns Pharmaceuticals, Inc."
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:34:22.596645+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Terns Pharmaceuticals extends office lease for 36 months through October 2027

## Summary
- Lease extended from Nov 1, 2024 to Oct 31, 2027 for 9,751 sq ft in Foster City, CA.
- Monthly base rent: $0 (Nov '24-Jan '25), then $43,879.50 rising to $46,551.76 by 2026-27.
- Tenant pays $43,789.50 as prepaid rent for Feb 2025 upon execution of amendment.
- Option to extend for additional three years with 9-12 months written notice; first refusal right deleted.
- Landlord may convert building to life science lab; tenant gets rent abatement and termination rights for significant disruption.

## SEC filing metadata
- accession: 0000950170-24-081531
- form_type: 8-K
- ticker: TERN
- cik: 0001831363
- company_name: Terns Pharmaceuticals, Inc.
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831363/000095017024081531/0000950170-24-081531-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831363/000095017024081531/tern-20240701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-081531
- JSON: https://secwatch.observer/filing/0000950170-24-081531.json
- Plain text: https://secwatch.observer/filing/0000950170-24-081531.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.